GlassScriptPhysician profile
Caleb R Campbell
NPI 1275844573
$569.81
in general payments reported to CMS, 2019-2025
12 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.65 · 2020: $14.20 · 2022: $243 · 2023: $21.21 · 2024: $121 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $244.75 | 2019-2024 | Aptus |
| Vertex Pharmaceuticals Incorporated | $53.45 | 2025 | |
| Endo Pharmaceuticals INC. | $53.10 | 2019-2020 | |
| Bioventus LLC | $33.64 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $33.36 | 2024 | Exparel |
| Stryker Corporation | $33.28 | 2025 | Inspace |
| Mid-Atlantic Surgical Systems, LLC | $28.63 | 2024 | |
| Medtronic, INC. | $22.51 | 2024 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $21.21 | 2023 | Tenoglide |
| Endo USA, INC. | $16.69 | 2025 | Xiaflex |
| Ferring Pharmaceuticals INC. | $16.14 | 2022 | |
| Zimvie INC. | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.